CLPBY(CLPBY)
CLPBY
No analyst ratings available
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $29.24B | $31.22B | $33.22B | $35.77B | $38.33B |
| Low | $28.97B | $30.89B | $32.91B | $35.44B | $37.97B |
| High | $29.59B | $31.48B | $33.62B | $36.20B | $38.79B |
| EBITDA Avg | $9.93B | $10.33B | $11.09B | $12.19B | $12.94B |
| Low | $9.73B | $9.95B | $10.98B | $12.07B | $12.81B |
| High | $10.13B | $10.53B | $11.22B | $12.34B | $13.10B |
| EBIT Avg | $8.57B | $8.88B | $9.54B | $10.53B | $11.16B |
| Low | $8.37B | $8.49B | $9.43B | $10.41B | $11.04B |
| High | $8.76B | $9.07B | $9.67B | $10.68B | $11.33B |
| Net Income Avg | $5.80B | $6.03B | $6.52B | $7.26B | $7.73B |
| Low | $5.65B | $5.74B | $6.44B | $7.17B | $7.64B |
| High | $5.94B | $6.17B | $6.62B | $7.37B | $7.85B |
| EPS Avg | $2.57 | $2.68 | $2.89 | $3.22 | $3.43 |
| Low | $2.51 | $2.55 | $2.86 | $3.18 | $3.39 |
| High | $2.64 | $2.74 | $2.94 | $3.27 | $3.48 |
| Analysts (Rev / EPS) | 10 / 2 | 11 / 2 | 8 / 1 | 10 / 1 | 5 / 1 |
| Metric | Q3 2026 | Q4 2026 |
|---|---|---|
| Revenue Avg | $7.44B | $7.38B |
| Low | $7.31B | $7.25B |
| High | $7.54B | $7.48B |
| EBITDA Avg | $2.22B | $2.62B |
| Low | $2.18B | $2.57B |
| High | $2.25B | $2.66B |
| EBIT Avg | $1.84B | $2.25B |
| Low | $1.81B | $2.20B |
| High | $1.87B | $2.28B |
| Net Income Avg | $1.25B | $1.55B |
| Low | $1.22B | $1.51B |
| High | $1.27B | $1.57B |
| EPS Avg | $0.55 | $0.69 |
| Low | $0.54 | $0.67 |
| High | $0.56 | $0.70 |
| Analysts (Rev / EPS) | 4 / 1 | 2 / 1 |